Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |